Heterogeneous clearance of antithymocyte globulin after CD34+ -selected allogeneic hematopoietic progenitor cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 8, 2005, Pages 609-618

  Kakhniashvili, Irina ^a   Filicko, Joanne ^a   Kraft, Walter K ^b   Flomenberg, Neal ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antilymphocyte globulin; Antithymocyte globulin; Donor lymphocyte infusion; Hematopoietic stem cell transplantation; Immune reconstitution; T cell depletion

Indexed keywords

AMPHOTERICIN; CD34 ANTIGEN; COTRIMOXAZOLE; CYTARABINE; FLUDARABINE; MELPHALAN; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; CANCER CLASSIFICATION; CD34 SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; LYMPHOCYTE HOMING; MALE; MYCOSIS; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ADULT; AGED; ANTIGENS, CD34; ANTILYMPHOCYTE SERUM; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 22344447874     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.05.001     Document Type: Article

References (15)

1. M. Buchler G. Thibault A. al Najjar et al. Monitoring of ATG therapy by flow cytometry and lymphocyte counts in renal transplantation Transplant Proc 28 1996 2817-2818
2. D. Bunn C. Lea D.J. Bevan R.M. Higgins B.M. Hendry The pharmacokinetics of anti-thymocyte globulin (ATG) following intravenous infusion in man Clin Nephrol 45 1996 29-32
3. F. Aversa A. Tabilo A. Velardi et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype N Engl J Med 339 1998 1186-1193
4. S.B. Killick J.C. Marsh E.C. Gordon-Smith L. Sorlin F.M. Gibson Effect of antithymocyte globulin on bone marrow CD34+ cells in aplastic anemia and myelodysplasia Br J Haematol 108 2000 582-591
5. E. Meijer A.C. Bloem A.W. Dekker L.F. Verdonck Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell-depleted bone marrow transplantation: A comparison between recipients of matched related and matched unrelated donor grafts Transplantation 75 2003 1910-1913
6. A. Baciagalupo T. Lamparelli P. Bruzzi et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) Blood 98 2001 2942-2947
7. J. Finke H. Bertz C. Schmoor et al. Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin Br J Haematol 111 2000 303-313
8. A. Baciagalupo R. Oneto T. Lamparelli et al. Pre-emptive therapy of acute graft-versus-host disease: A pilot study with antithymocyte globulin (ATG) Bone Marrow Transplant 28 2001 1093-1096
9. X. Preville M. Flacher B. LeMauff et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model Transplantation 71 2001 460-468
10. A. Bartholomew D. Sher S. Sosler et al. Stem cell transplantation eliminates alloantibody in a highly sensitized patient Transplantation 72 2001 1653-1655
11. E.K. Waller A.A. Longston S. Lonial et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation Biol Blood Marrow Transplant 9 2003 460-471
12. J. Gabrielsson D. Weiner Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts & Applications 3rd ed 2001 Swedish Pharmaceutical Press Stockholm, Sweden 261
13. I. Redei A.A. Langston S. Lonial et al. Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors Bone Marrow Transplant 30 2002 335-340
14. N. Kroger T. Zabelina W. Kruger et al. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin Br J Haematol 113 2001 1060-1071
15. T.H. Eiermann P. Lambrecht A.R. Zander Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients Bone Marrow Transplant 23 1999 779-781